Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niv Papo

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Scientific Reports|March 30, 2023
Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14Hezi Hayun, Matt Coban, Ashok Kumar Bhagat, et al.
Nuclear Medicine and Biology|May 4, 2024
PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranosticsTruc T Huynh, Yutian Feng, Rebecca Meshaw, et al.
The Journal of Biological Chemistry|June 24, 2018
A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineeringAmiram Sananes, Itay Cohen, Anat Shahar, et al.
Research Square|January 30, 2023
Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14Hezi Hayun, Matt Coban, Ashok Kumar Bhagat, et al.
The Journal of Biological Chemistry|February 1, 2019
Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsinItay Cohen, Matt Coban, Anat Shahar, et al.
The Biochemical Journal|June 29, 2017
Engineering a monomeric variant of macrophage colony-stimulating factor (M-CSF) that antagonizes the c-FMS receptorYuval Zur, Lior Rosenfeld, Anna Bakhman, et al.
Plos Biology|August 25, 2018
A dual-specific macrophage colony-stimulating factor antagonist of c-FMS and αvβ3 integrin for osteoporosis therapyYuval Zur, Lior Rosenfeld, Chen Anna Keshelman, et al.
ACS Chemical Neuroscience|April 27, 2021
A Mechanism for the Inhibition of Tau Neurotoxicity: Studies with Artificial Membranes, Isolated Mitochondria, and Intact CellsSegev Naveh Tassa, Shani Ben Zichri, Shiran Lacham-Hartman, et al.
Cell Death & Disease|January 27, 2018
MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALSNeta Shvil, Victor Banerjee, Guy Zoltsman, et al.
Molecular Oncology|August 23, 2023
Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancersAmiram Sananes, Itay Cohen, Irit Allon, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Scientific Reports|March 30, 2023
Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14Hezi Hayun, Matt Coban, Ashok Kumar Bhagat, et al.
Nuclear Medicine and Biology|May 4, 2024
PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranosticsTruc T Huynh, Yutian Feng, Rebecca Meshaw, et al.
The Journal of Biological Chemistry|June 24, 2018
A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineeringAmiram Sananes, Itay Cohen, Anat Shahar, et al.
Research Square|January 30, 2023
Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14Hezi Hayun, Matt Coban, Ashok Kumar Bhagat, et al.
The Journal of Biological Chemistry|February 1, 2019
Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsinItay Cohen, Matt Coban, Anat Shahar, et al.
The Biochemical Journal|June 29, 2017
Engineering a monomeric variant of macrophage colony-stimulating factor (M-CSF) that antagonizes the c-FMS receptorYuval Zur, Lior Rosenfeld, Anna Bakhman, et al.
Plos Biology|August 25, 2018
A dual-specific macrophage colony-stimulating factor antagonist of c-FMS and αvβ3 integrin for osteoporosis therapyYuval Zur, Lior Rosenfeld, Chen Anna Keshelman, et al.
ACS Chemical Neuroscience|April 27, 2021
A Mechanism for the Inhibition of Tau Neurotoxicity: Studies with Artificial Membranes, Isolated Mitochondria, and Intact CellsSegev Naveh Tassa, Shani Ben Zichri, Shiran Lacham-Hartman, et al.
Cell Death & Disease|January 27, 2018
MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALSNeta Shvil, Victor Banerjee, Guy Zoltsman, et al.
Molecular Oncology|August 23, 2023
Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancersAmiram Sananes, Itay Cohen, Irit Allon, et al.
Pageof 9